ESPAD Survey: Vaping Prevalent among European Students

Sep.01.2022
ESPAD Survey: Vaping Prevalent among European Students
The ESPAD project investigates alcohol, tobacco, and drug use among 15-16 year old students in 35 European countries.

The European School Survey Project on Alcohol and Other Drugs (ESPAD) is the largest survey of alcohol, tobacco, and illegal drug use among 15-16 year old students in 35 European countries. It is coordinated by the Institute of Clinical Physiology of the National Research Council of Italy (CNR-Ifc). Using standardized methods since 1999, this survey is able to assess changes in young people's habits and has recently garnered interest from the World Health Organization.


Data shows that traditional tobacco cigarette use is declining among adolescents, possibly due to prevention and comparison policies implemented in many countries. However, concerning data about electronic cigarette use has emerged as a worrying trend. In response, the epidemiology and health services research department of CNR-Ifc conducted a study titled "Electronic Cigarette Use and Conventional Smoking Among European Students: Results From the 2019 ESPAD Survey," published in the journal Addiction, to analyze how tobacco control policies impact these habits.


In 2019, a study of approximately 100,000 ESPAD students found that 40.6% had tried traditional cigarettes at least once, with 19.3% currently being smokers. The percentage of smokers varied from 5.1% in Iceland to 32.4% in Italy. On the other hand, 37.8% of students reported trying e-cigarettes, with 12.4% currently using them (13.4% in Italy). According to the study's author, Sonia Cerrai, it can be assumed that young people's attitudes towards new smoking habits will continue to grow, due to the ease of access and perception of low risk.


In the ten countries analyzed, the use of electronic cigarettes has surpassed traditional smoking," stated Cerrai. "While electronic cigarettes may not necessarily contain nicotine, these tech products that are highly attractive to young people and very young individuals are frequently used in conjunction with traditional cigarettes, with usage ranging from 2% in Cyprus to 15% in Monaco (8.9% in Italy) within the sample.


However, implementing tobacco control policies by the government can also contribute to preventing smoking. "In this analysis, we used the Tobacco Control Scale index, which scores policies based on the measures taken," explained Cerrai. "We also considered some specific factors in our analysis: price increases showed a clear association with decreased use of two smoking methods. More spending on information campaigns and cessation programs only correlated with traditional smoking, while measures to prohibit the promotion and advertising of electronic devices were stricter.


According to researchers, the marketing for new devices emphasizes safety by reducing the risks associated with tobacco smoke exposure. However, this complete change in consumption patterns could lead to distractions for young people, who are also familiar with prevention initiatives and programs implemented in the past 20 years.


Statement: 1. The content of this article is compiled from third-party information, provided solely for industry exchange and learning purposes. 2. This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity and accuracy of the article's content. The compilation of this article is only for industry exchange and research purposes. 3. Due to limitations in the compilation process, the compiled article may not fully match the original text. Please refer to the original text for accuracy. 4. 2FIRSTS fully aligns with the Chinese government on any statements and positions related to domestic, Hong Kong, Macau, Taiwan, and foreign issues. 5. Copyright for compiled information belongs to the original media and author. Please contact us for removal if there is any infringement.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

 Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays
Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays
According to Reuters, Philip Morris International (PMI) lowered its 2026 adjusted earnings-per-share forecast amid regulatory uncertainty around Zyn nicotine pouches, rising competition and shipment pressure in the U.S. market.
PMI
Jun.02
Opinion | As EU Reviews Tobacco Rules, Experts Warn Against Overlooking Smokers’ Alternatives
Opinion | As EU Reviews Tobacco Rules, Experts Warn Against Overlooking Smokers’ Alternatives
As the European Commission reviews its tobacco and advertising rules, two experts who provided written comments to 2Firsts argue that future EU policy should not overlook adult smokers’ alternatives. Dr Garrett McGovern and Dr Carmen Escrig say regulators should weigh relative risk, adult switching, flavours, consumer behaviour and scientific uncertainty alongside youth protection.
Industry Insight
Jun.01
Capital Group Takes 5.61% Stake in KT&G, Joining Major Foreign Shareholders
Capital Group Takes 5.61% Stake in KT&G, Joining Major Foreign Shareholders
KT&G disclosed in a regulatory filing on Friday that Capital Research and Management Company, the investment management arm of Capital Group, had acquired a 5.61% stake through purchases made on April 22 and May 4. The move places Capital Group among KT&G’s prominent foreign shareholders, alongside BlackRock, First Eagle Investment Management and Singapore’s sovereign wealth fund GIC.
May.08 by 2FIRSTS.ai
PML Expands Its UK Smoke-Free Portfolio With LEVIA
PML Expands Its UK Smoke-Free Portfolio With LEVIA
Philip Morris Limited has launched LEVIA, a new range of zero-tobacco flavored nicotine sticks created for the IQOS ILUMA range. The product expands the company’s smoke-free portfolio in the UK and will initially be available in four variants, including Deep Mint and three capsule-based flavors. LEVIA has a recommended retail price of £5, or about $6.73, based on the European Central Bank’s April 28.
Apr.29 by 2FIRSTS.ai
Product|PMI Expands High-Strength Nicotine Pouch Portfolio With Zyn 16.5mg
Product|PMI Expands High-Strength Nicotine Pouch Portfolio With Zyn 16.5mg
According to Better Retailing, Philip Morris International (PMI) has launched Zyn Menthol Ice 16.5mg in the UK, marking the highest-strength nicotine pouch in the Zyn range to date. The eucalyptus- and menthol-flavored product is now available through PMI Open and will begin rolling out to wholesale channels from the end of May.
PMI
May.28
One Nation Proposes 50% Tobacco Excise Cut as Australia’s Illicit Market Expands
One Nation Proposes 50% Tobacco Excise Cut as Australia’s Illicit Market Expands
Australian One Nation leader Pauline Hanson has proposed cutting tobacco excise by 50% and freezing indexation until June 30, 2028, in a bid to lower legal cigarette prices and reduce the price advantage of the illicit tobacco market.
Jun.18